Investor Presentation
ASSETS UNDER MANAGEMENT
In €m
31/12/2020
31/12/2021
Change (%)
VS.
NAV
3rd party AUM
Total AUM
NAV
3rd party AUM
Total AUM
31/12/2020
Private Equity, Eurazeo
4,536
8,465
13,001
6,192
12,677
18,869
45%
Mid-large buyout
2,523
1,226
3,749
3,056
1,818
4,874
30%
Small-mid buyout
570
470
1,040
760
1,110
1,870
80%
Growth
1,000
845
1,845
1,606
2,596
4,203
126%
Brands
Healthcare
Venture
Private Funds
425
425
718
718
69%
415
415
413
413
n.s.
18
2,472
2,490
47
3,086
3,133
26%
3,038
3,038
5
3,654
3,659
20%
Private Debt
21
4,308
4,329
83
5,886
5,968
38%
Real Assets, Eurazeo
1,020
51
1,071
1,244
221
1,464
37%
Rhône (30%)
1,839
1,839
2,097
2,097
14%
MCH Private Equity (25%)
220
220
280
280
27%
Kurma (100%)
132
132
383
383
190%
Total Portfolio
5,577
15,015
20,592
7,518
21,543
29,061
41%
Asset Management¹
1,440
1,440
1,954
1,954
36%
Net cash and other items²
-271
-271
-143
-143
n.s.
Total
6,746
15,015
21,760
9,329
21,543
30,872
42%
EURAZEO
1.
2.
Equity value for Eurazeo Group, Rhône, MCH, IMG and Eurazeo's GP fund management activities.
Including Eurazeo's commitment as LP outside the Group
39
INVESTOR PRESENTATIONView entire presentation